Combination of furosemide and albumin for treatment of edema in chronic kidney disease patients

Phase 4

Completed

• Conditions: Edema; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12611000480987
• Lead Sponsor: Ramathibodi research fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-10
• Study Completion: 2012-01-01
• Last Update Posted: 16 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Stable CKD patients were defined as patients who have GFR < 60 mL/min per 1.73m2 and no fluctuation of GFR > 10% with in 2 months

Exclusion Criteria

Patients with GFR < 10 mL/min per 1.73m2, critically ill patients such as congestive heart failure, acute renal failure, shock, on respirator and previous history of furosemide usage within two week

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Volume of urine output (mL)<br>compare the average increment of urine out put at 6 hour and at 24 hour between 2 interventions by using pair t test[At 6 and 24 hour after treatment];Urine sodium (mEq)<br>compare the average increment of urine sodium at 6 hour and at 24 hour between 2 interventions by using pair t test[At 6 and 24 hour after treatment]

Secondary Outcome Measures

Name	Time	Method
none[none]